mMRP: Pilot Trial of Mobile Mantram Delivery

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT05998967
Collaborator
(none)
36
1
2
10
3.6

Study Details

Study Description

Brief Summary

Mantram Repetition Program (MRP) is a meditation practice that involves silent repetition of a spiritual word, one-pointed attention, and slowing down. It has been shown to help reduce PTSD symptoms among Veterans. This study will look at how Veterans reach to learning MRP via the Internet, either in a self-directed way or with text/phone support.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mobile Mantram Repetition Program
N/A

Detailed Description

Easily accessible interventions to address post-traumatic stress disorder (PTSD) can play critical role in reducing PTSD and associated symptoms in Veterans, especially for those who remain symptomatic after treatment with other evidence-based interventions, those who prefer complimentary and integrative therapies, or those who have difficulty accessing traditional face-to-face mental health services. The value of these programs is their ability to provide Veterans with more options in their recovery journey and to reach a broad range of Veterans across multiple settings, including remote rural contexts.

The Mantram Repetition Program (MRP) is a meditation-based practice that consists of the repetition of a spiritual word, one-pointed attention, and slowing down. MRP has been shown to reduce stress in several high-risk populations, and two large randomized, controlled studies show that MRP reduces PTSD symptoms among Veterans. A brief, web-based, self-directed version of MRP has been developed to increase the accessibility of evidence-based PTSD treatment. This version of MRP was tested in a pilot study with undergraduate students, demonstrating its ease of use and success in getting students to engage with the practice. The proposed mixed method study will use the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework to evaluate the mobile MRP in Veterans with PTSD in two conditions: self-directed and with text/phone support. Data from this pilot study will inform the refinement of the MRP delivery strategy and the development of a full-scale trial to test its effectiveness and implementation outcomes, as well as barriers and facilitators, and other contextual factors.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Internet-based instruction in MRP in a self-directed or supported mannerInternet-based instruction in MRP in a self-directed or supported manner
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Feasibility and Acceptability of Mobile Mantram Repetition Program for Veterans With PTSD (IVI 22-115)
Actual Study Start Date :
Dec 1, 2021
Actual Primary Completion Date :
Sep 30, 2022
Actual Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Self-directed MRP

Self-directed instruction in MRP via Internet

Behavioral: Mobile Mantram Repetition Program
Internet-based instruction in a meditation practice that involves silent repetition of a spiritual word, one-pointed attention and slowing down
Other Names:
  • mMRP
  • Active Comparator: Supported MRP

    Supported instruction in MRP via Internet

    Behavioral: Mobile Mantram Repetition Program
    Internet-based instruction in a meditation practice that involves silent repetition of a spiritual word, one-pointed attention and slowing down
    Other Names:
  • mMRP
  • Outcome Measures

    Primary Outcome Measures

    1. Eligibility rate [Day 0]

      Rate of eligibility among those screened for participation

    2. Initiation rate [Day 1]

      Rate of intervention initiation among eligible Veterans

    3. Completion rate [Day 28]

      Rate of intervention completion among eligible Veterans

    4. Credibility [Day 1]

      Average Veteran perception of the logic, utility and expected benefit of treatment rated on a scale of 0 (not at all) to 8 (very)

    5. Client Satisfaction Questionnaire (CSQ-8) [Day 28]

      Degree of satisfaction with care received as measured by a CSQ-8 total score. Scores range from 8-32 with higher scores indicating greater satisfaction.

    6. Acceptability of Intervention Measure (AIM) [Day 28]

      Perceived acceptability of the intervention as measured by an AIM average score. Scores range from 1-5 with higher scores indicating greater acceptability.

    7. Intervention Appropriateness Measure (IAM) [Day 28]

      Perceived appropriateness of the intervention as measured by an IAM average score. Scores range from 1-5 with higher scores indicating greater appropriateness.

    8. Feasibility of Intervention Measure (FIM) [Day 28]

      Perceived feasibility of the intervention as measured by an FIM average score. Scores range from 1-5 with higher scores indicating greater feasibility.

    Secondary Outcome Measures

    1. Mantram practice [Weeks 2-4]

      Frequency of mantram practice in the past week as 0-7 days

    2. PTSD Checklist for DSM-5 (PCL-5) [Day 0-28]

      Change in PTSD symptoms from baseline to post-treatment as measured by change in the PCL-5 total score. Scores range from 0-80 with higher scores indicating greater PTSD symptoms.

    3. Patient Health Questionnaire depression items (PHQ-9) [Day 0-28]

      Change in depression from baseline to post-treatment as measured by change in the PHQ-9 total score. Scores range from 0-27 with higher scores indicating greater depression.

    4. Insomnia Severity Index [Day 0-28]

      Change in insomnia from baseline to post-treatment as measured by change in the ISI total score. Scores range from 0-28 with higher scores indicating greater insomnia.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Veteran

    • Primary clinical complaint of PTSD

    • Access to an Internet-enabled device

    Exclusion Criteria:
    • Cognitive impairment or mental health concerns that necessitated a higher level of care or interfered with ability to engage in study activities

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 VA San Diego Healthcare System, San Diego, CA San Diego California United States 92161-0002

    Sponsors and Collaborators

    • VA Office of Research and Development

    Investigators

    • Principal Investigator: Ariel J. Lang, PhD, VA San Diego Healthcare System, San Diego, CA

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    VA Office of Research and Development
    ClinicalTrials.gov Identifier:
    NCT05998967
    Other Study ID Numbers:
    • IVX 23-001
    • SWIFT-IVI 22-115
    First Posted:
    Aug 21, 2023
    Last Update Posted:
    Aug 21, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by VA Office of Research and Development

    Study Results

    No Results Posted as of Aug 21, 2023